Pfizer Worldwide Research & Development (WRD)
United States of America (USA)
1 December 2019 - 30 November 2020
Principal institution: Pfizer Inc.
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Pfizer Worldwide Research & Development (WRD) published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 14 | 4.43 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Chemistry | 7 | 3.72 | |
| Life Sciences | 7 | 0.70 | |
| Journal of Clinical Investigation | 1 | 0.63 | |
| Molecular Psychiatry | 1 | 0 | |
| Nature | 2 | 0.04 | |
| Nature Communications | 3 | 0.04 | |
Top articles by Altmetric score in current window
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
Nature Communications
2020-01-09
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
Nature Communications
2020-02-03
A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank
Nature Communications
2020-05-08
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
